- Home
- LPCN vs CCM Comparison
LPCN vs CCM Comparison
Compare LPCN & CCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPCN
- CCM
- Stock Information
- Founded
- LPCN 1997
- CCM 1997
- Country
- LPCN United States
- CCM China
- Employees
- LPCN N/A
- CCM N/A
- Industry
- LPCN Biotechnology: Pharmaceutical Preparations
- CCM Medical/Nursing Services
- Sector
- LPCN Health Care
- CCM Health Care
- Exchange
- LPCN Nasdaq
- CCM Nasdaq
- Market Cap
- LPCN 16.1M
- CCM 18.2M
- IPO Year
- LPCN N/A
- CCM 2009
- Fundamental
- Price
- LPCN $3.10
- CCM $4.73
- Analyst Decision
- LPCN Strong Buy
- CCM
- Analyst Count
- LPCN 1
- CCM 0
- Target Price
- LPCN $10.00
- CCM N/A
- AVG Volume (30 Days)
- LPCN 10.3K
- CCM 29.8K
- Earning Date
- LPCN 05-08-2025
- CCM 05-02-2025
- Dividend Yield
- LPCN N/A
- CCM N/A
- EPS Growth
- LPCN N/A
- CCM N/A
- EPS
- LPCN N/A
- CCM N/A
- Revenue
- LPCN $11,198,144.00
- CCM $64,910,622.00
- Revenue This Year
- LPCN N/A
- CCM N/A
- Revenue Next Year
- LPCN N/A
- CCM N/A
- P/E Ratio
- LPCN N/A
- CCM N/A
- Revenue Growth
- LPCN N/A
- CCM N/A
- 52 Week Low
- LPCN $2.75
- CCM $3.80
- 52 Week High
- LPCN $11.79
- CCM $26.70
- Technical
- Relative Strength Index (RSI)
- LPCN 46.56
- CCM 58.04
- Support Level
- LPCN $2.82
- CCM $3.88
- Resistance Level
- LPCN $3.27
- CCM $4.55
- Average True Range (ATR)
- LPCN 0.23
- CCM 0.39
- MACD
- LPCN 0.01
- CCM 0.07
- Stochastic Oscillator
- LPCN 58.92
- CCM 84.16
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.
About CCM Concord Medical Services Holdings Limited
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company operates cooperative centers across several provinces and administrative regions in China. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services, such as electroencephalography for the diagnosis of epilepsy, thermotherapy to increase the efficacy of and for pain relief after radiotherapy and chemotherapy, high-intensity focused ultrasound therapy for the treatment of cancer, stereotactic radiofrequency ablation for the treatment of Parkinson's Disease and refraction and tonometry for the diagnosis of ophthalmic conditions.